The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
Abstract Dendritic cells (DCs) can initiate and direct adaptive immune responses. This ability is exploitable in DC vaccination strategies, in which DCs are educated ex vivo to present tumor antigens and are administered into the patient with the aim to induce a tumor-specific immune response. DC va...
Main Authors: | Kalijn F. Bol, Gerty Schreibelt, Katrin Rabold, Stefanie K. Wculek, Julia Katharina Schwarze, Andrzej Dzionek, Alvaro Teijeira, Lana E. Kandalaft, Pedro Romero, George Coukos, Bart Neyns, David Sancho, Ignacio Melero, I. Jolanda M. de Vries |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-04-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0580-6 |
Similar Items
-
Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets
by: Florian eWimmers, et al.
Published: (2014-04-01) -
Quantification of dendritic cell subsets in human thymus tissues of various ages
by: Yan Li, et al.
Published: (2021-11-01) -
Cutaneous blastic plasmacytoid dendritic cell neoplasm: Report of a case and review of the literature
by: Chien-yio Lin, et al.
Published: (2017-06-01) -
Regulation of the Migration of Distinct Dendritic Cell Subsets
by: Meng Feng, et al.
Published: (2021-02-01) -
Plasmacytoid dendritic cells: Development, functions, and role in atherosclerotic inflammation
by: Dimitry A Chistiakov, et al.
Published: (2014-07-01)